These findings indicated firstly that leptin reduced LDLR levels in hepatocyte via PCSK9 pathway, suggesting that PCSK9 might be a alternative target for dyslipidemia in the obesity. The gene discussed is LDLR; the disease is obesity due to melanocortin 4 receptor deficiency.